Related Experiment Video
Updated: Aug 20, 2026

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids
Published on: October 14, 2019
Endocrine tumor syndromes in infancy and childhood
1Department of Pathology, Josephine Nefkens Institute, Erasmus MC-University Medical Center, Rotterdam, The Netherlands. r.dekrijger@erasmusmc.nl
Abstract:
Of endocrine disorders that present in the pediatric age range, three heritable tumor syndromes have received a large amount of attention over the past decade, because the relevant genes have been discovered and we have begun to understand the role of some of the proteins involved. In this short review article, the dominantly inherited tumor syndromes multiple endocrine neoplasia type 1 (MEN1), caused by mutations in the menin gene, type 2 (MEN2), caused by mutations in the RET protooncogene, and von Hippel-Lindau disease (VHL), caused by VHL gene abnormalities including mutations, are discussed with an emphasis on the age and mode of presentation of the constituent tumors. Also, current screening and/or treatment guidelines are included.
Insights
This review covers three pediatric endocrine tumor syndromes: multiple endocrine neoplasia type 1 (MEN1), type 2 (MEN2), and von Hippel-Lindau disease (VHL). It details their genetic basis, tumor presentation, and current management guidelines.
Area of Science:
- Pediatric Endocrinology
- Oncology
- Genetics
Background:
- Heritable tumor syndromes are a significant concern in pediatric endocrinology.
- Recent advances in gene discovery have improved understanding of these disorders.
- Multiple endocrine neoplasia types 1 and 2 (MEN1, MEN2) and von Hippel-Lindau disease (VHL) are key examples.
Purpose of the Study:
- To review three major heritable endocrine tumor syndromes in children.
- To emphasize the age and clinical presentation of tumors associated with these syndromes.
- To provide an overview of current screening and treatment guidelines.
Main Methods:
- Literature review focusing on genetic discoveries and clinical manifestations.
- Synthesis of information on MEN1, MEN2, and VHL disease.
- Inclusion of current screening and treatment recommendations.
Main Results:
- MEN1 is associated with mutations in the menin gene.
- MEN2 is linked to mutations in the RET protooncogene.
- VHL disease results from VHL gene abnormalities, including mutations.
Conclusions:
- Understanding the genetic basis of MEN1, MEN2, and VHL is crucial for pediatric endocrine tumor management.
- Early diagnosis and appropriate screening/treatment are vital for improving patient outcomes.
- This review provides a consolidated resource for clinicians managing these rare conditions.
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and lactation.
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Hypothyroidism II: Pathophysiology